Skip to navigation Skip to content
Active Featured

Active Featured

Medication News Analysis

  • Hematology
  • Neuroscience
  • Nutrition
  • Nanomedicine
Active Featured
  • Home
  • About Us
  • Contact Us
  • Our Team
  • Terms of Service
  • Privacy Policy
Active Featured

Active Featured

Medication News Analysis

  • Hematology
  • Neuroscience
  • Nutrition
  • Nanomedicine

Tag: BTK-CD20

  • Home
  • BTK-CD20
January 25, 20200

In Treatment-Naïve CLL Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS

At ASH 2019, they had the respect and benefit to introduce a front‑line investigation of acalabrutinib in patients with constant lymphocytic leukemia

Read More

Recent Posts

  • El Segundo Creative Marketing Agency | Consistent Brand Identity Report Launched
  • INTERNATIONAL LAND ALLIANCE, INC. ANNOUNCES LISTING OF EMERALD GROVE FOR $2.8M
  • Premium sherpa blanket Proudly Risks Defying Convention
  • Essential Oil For Classrooms & Back to School Home Study Learning Guide Released
  • Lendzero Launches its pre-negotiated, zero-haggle Business Funding Program

Categories

  • Cloud PRwire
  • Hematology
  • Nanomedicine
  • Neuroscience
  • Nutrition
  • Press Release
WordPress Theme : VMagazine Lite